open access

Vol 72, No 1 (2021)
Clinical vignette
Published online: 2021-01-11
Submitted: 2020-12-13
Accepted: 2020-12-14
Get Citation

Adjuvant therapy in type 1 diabetes mellitus

Edyta Cichocka, Anna Maj-Podsiadło, Janusz Gumprecht
DOI: 10.5603/EP.a2021.0003
·
Pubmed: 33619718
·
Endokrynologia Polska 2021;72(1):87-88.

open access

Vol 72, No 1 (2021)
Clinical Vignette
Published online: 2021-01-11
Submitted: 2020-12-13
Accepted: 2020-12-14

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

type 1 diabetes mellitus; adjuvant therapy

About this article
Title

Adjuvant therapy in type 1 diabetes mellitus

Journal

Endokrynologia Polska

Issue

Vol 72, No 1 (2021)

Article type

Clinical vignette

Pages

87-88

Published online

2021-01-11

DOI

10.5603/EP.a2021.0003

Pubmed

33619718

Bibliographic record

Endokrynologia Polska 2021;72(1):87-88.

Keywords

type 1 diabetes mellitus
adjuvant therapy

Authors

Edyta Cichocka
Anna Maj-Podsiadło
Janusz Gumprecht

References (6)
  1. Polsky S, Ellis SL. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2015; 22(4): 277–282.
  2. Al Khalifah RA, Alnhdi A, Alghar H, et al. The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: A systematic review and meta-analysis. Pediatr Diabetes. 2017; 18(7): 664–673.
  3. Libman IM, Miller KM, DiMeglio LA, et al. T1D Exchange Clinic Network Metformin RCT Study Group. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2015; 314(21): 2241–2250.
  4. Maj-Podsiadło A, Cichocka E, Gumprecht J. SGLT-2 inhibitors as adjunctive to insulin therapy in type 1 diabetes. Clin Diabetol. 2020; 9(3): 189–192.
  5. Huang Y, Jiang Z, Wei Y. Short- and medium-term efficacy of sodium glucose cotransporter 2 (SGLT-2) inhibitors for the treatment of type 1 diabetes: systematic review and meta-analysis. Endokrynol Pol. 2020; 71(4): 325–333.
  6. Mathieu C, Zinman B, Hemmingsson JU, et al. ADJUNCT ONE Investigators. Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial. Diabetes Care. 2016; 39(10): 1702–1710.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl